We conduct research within clinical studies of acute poisonings, in particular regarding epidemiology, new diagnostic methods, treatment, complications and prognosis.
Alzheimer’s disease is the most common cause of age-related dementia, and a major societal problem due to the lack of efficacious therapeutics.
We aim to contribute with increased knowledge within the field of ophthalmology. Our research projects include glaucoma and diseases, as well as conditions related to the cornea and the lens.
The aim of this research group is to explore metabolic aberrations in endocrine diseases for the identification and validation of new biomarkers.
The group investigates biological mechanisms in severe mental disorders to increase the knowledge of these disorders with potential implications for prevention, treatment, course prediction and diagnostics.
Blood cells have various tasks. We study mechanisms regulating inflammation and coagulation, with focus on extracellular vesicles.
The overall goals of the research group are 1) to increase our knowledge of adult brain plasticity and its roles in neurological and psychiatric disorders and 2) to bridge the gap between neurological and psychiatric research.
Our research group focus on treatment, prognostication and outcome after critical conditions for the heart and the brain.
Sudden cardiac death due to cardiac arrhythmia is one of the most common causes of death in Norway. In young people it is often caused by a hereditary heart disease.
The research group is primarily engaged in researcher initiated studies of hypertension as a risk factor for cardiovascular and renal disease. We want to improve our understanding of the patients' perspectives by investigating new methods to improve adherence to antihypertensive medications.
The Cardiovascular Research Group (CRG) conducts high-quality, translational and clinical-epidemiological research with the overarching aim to promote personalized therapy in cardiovascular medicine.
We do research on venous thrombosis and malignant hematological diseases. Our main focus are clinical trials of venous thrombosis, chronic lymphatic leukemia, and acute myeloid leukemia in elderly.
Our research group's main goal is to better understand basic molecular and cellular adaptive immunology, and to translate this knowledge into improved vaccines and treatments against infectious diseases and cancer.
We investigate genome dynamics with particular emphasis on oxidative stress, DNA base lesion repair and maintenance of epigenetic DNA methylation (epigenome stability).
The group has broad interest in atherosclerosis, inflammation and acute stroke, including multi-modal imaging methods such as MRI, PET and ultrasound.
The research group studies mental illness among children and adolescents by using a variety of methods and perspectives.
Human immunodeficiency virus (HIV), tuberculosis (TB), Hepatitis B (HBV), sepsis, influenza and COVID-19 are all globally dominant infections with increased or dysregulated inflammation important for the outcome of the disease.
The research profile is to test and develop new technologies in perioperative patient monitoring.
Our group conducts experimental and clinical research to study effects of hypoxia and other pulmonary diseases on heart and lungs.
Our research group is focusing its investigations on the main topic of ischemic heart disease, and extends its approach to adjacent research fields such as heart failure and atrial fibrillation.
Akershus University Hospital has since 2006 studied clinical communication.
Our overall goal is to establish early diagnostics and intervention for diseases that affect the nervous system.
The main purpose of our research group is to promote quality and gain new knowledge in clinical newborn medicine.
We perform translational research from basic radiology science to clinical research, pure clinical research and quality control studies in order to find new methods, improve methods, and control our work in order to keep high standards.
The research group studies causes and risk factors for suicide and self-harming behaviour, and evaluates and develops treatment methods.